Chemoradiotherapy for rectal cancer - When, why, and how?

New England Journal of Medicine

Volumn 351, Issue 17, 2004, Pages 1790-1792

  Madoff, Robert D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; COLON CANCER; EDITORIAL; HUMAN; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; METHODOLOGY; MORTALITY; NOTE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY; RECTUM TUMOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 6044274527     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe048213     Document Type: Editorial

References (12)

1. NIH consensus conference: adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
2. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2:996-9.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
4. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000;356:93-6.
5. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7. [Erratum, N Engl J Med 1997;336:1539.]
6. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7. [Erratum, N Engl J Med 1997;336:1539.]
7. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
8. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
9. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
10. Holm T, Singnomklao T, Rutqvist LE, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma: adverse effects during long term follow-up of two randomized trials. Cancer 1996;78:968-76.
11. Kollmorgen CF, Meagher AP, WoIff BG, Pemberton JH, Martenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-82.
12. Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 1998;41:543-51.